Skip to main content

Table 3 Recovery, Intraday and Interday precision of LCFAs

From: Serum lipidomic study of long-chain fatty acids in psoriasis patients prior to and after anti-IL-17A monoclonal antibody treatment by quantitative GC‒MS analysis with in situ extraction

LCFAs

Recovery (%)

Intraday precision (%)

(n = 5)

Interday precision (%)

(n = 5)

L

M

H

L

M

H

L

M

H

12:0

96.31

94.41

95.90

0.05

0.57

2.78

0.07

0.46

4.67

14:0

98.81

97.94

98.43

0.16

1.77

3.73

0.31

2.03

9.89

16:0

98.33

97.79

97.50

0.70

2.39

7.76

0.42

4.85

9.11

16:1

102.67

95.99

101.00

0.13

3.65

2.84

0.20

2.11

4.16

18:0

104.77

97.41

92.36

0.34

2.32

6.35

0.21

1.68

9.31

18:1

101.80

97.86

98.01

1.44

5.61

8.86

2.24

9.98

14.90

18:2

98.78

98.16

98.76

0.09

3.19

7.75

0.31

4.16

7.91

20:0

95.62

94.86

93.58

1.12

0.46

14.94

3.20

4.04

14.43

20:4

92.68

102.81

93.19

0.08

0.18

12.90

0.05

0.59

14.19

20:5

103.57

105.36

92.70

0.53

0.41

11.18

0.47

8.07

14.03

22:0

97.61

103.37

96.44

0.30

3.63

8.15

1.28

4.61

14.72

22:6

101.76

96.84

98.42

0.32

1.02

5.45

0.97

1.57

14.33

24:0

105.15

96.61

93.50

2.79

5.34

8.93

1.81

5.59

13.32

26:0

94.76

92.96

105.41

1.47

4.19

8.71

1.48

6.26

14.31

  1. L Low concentration, M Medium concentration, H High concentration